Back to GetFilings.com




 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 


 

FORM 10-Q

 

þ   QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2003

 

OR

 

¨   TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from . . . . . . . . . . to . . . . . . . . . .

 

Commission file number 333-76473

 


 

EQUISTAR CHEMICALS, LP

(Exact name of registrant as specified in its charter)

 


 

Delaware   76-0550481
(State or other jurisdiction of   (I.R.S. Employer
Incorporation or organization)   Identification No.)
1221 McKinney Street,    
Suite 700, Houston, Texas   77010
(Address of principal executive offices)   (Zip Code)

 

Registrant’s telephone number, including area code: (713) 652-7200

 


 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes ü     No    

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes         No ü

 

There is no established public trading market for the registrant’s equity securities.

 



PART I. FINANCIAL INFORMATION

 

EQUISTAR CHEMICALS, LP

 

ITEM 1. CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME

 

    

For the three

months ended

June 30,


    

For the six

months ended

June 30,


 

Millions of dollars


   2003

    2002

     2003

    2002

 

Sales and other operating revenues:

                                 

Trade

   $ 1,217     $ 1,111      $ 2,444     $ 2,006  

Related parties

     380       351        794       592  
    


 


  


 


       1,597       1,462        3,238       2,598  

Operating costs and expenses:

                                 

Cost of sales

     1,517       1,390        3,193       2,552  

Selling, general and administrative expenses

     44       41        84       81  

Research and development expense

     10       9        19       18  

Loss on sales of assets

     2       —          14       —    
    


 


  


 


       1,573       1,440        3,310       2,651  
    


 


  


 


Operating income (loss)

     24       22        (72 )     (53 )

Interest expense

     (56 )     (51 )      (106 )     (103 )

Interest income

     3       1        4       1  

Other income (expense), net

     (20 )     —          (21 )     1  
    


 


  


 


Loss before cumulative effect of accounting change

     (49 )     (28 )      (195 )     (154 )

Cumulative effect of accounting change

     —         —          —         (1,053 )
    


 


  


 


Net loss and comprehensive loss

   $ (49 )   $ (28 )    $ (195 )   $ (1,207 )
    


 


  


 


 

See Notes to the Consolidated Financial Statements.

 

1


EQUISTAR CHEMICALS, LP

 

CONSOLIDATED BALANCE SHEETS

 

Millions of dollars


   June 30,
2003


    December 31,
2002


 

ASSETS

                

Current assets:

                

Cash and cash equivalents

   $ 143     $ 27  

Accounts receivable:

                

Trade, net

     445       490  

Related parties

     114       135  

Inventories

     478       424  

Prepaid expenses and other current assets

     36       50  
    


 


Total current assets

     1,216       1,126  

Property, plant and equipment, net

     3,405       3,565  

Investments

     65       65  

Other assets, net

     343       296  
    


 


Total assets

   $ 5,029     $ 5,052  
    


 


LIABILITIES AND PARTNERS’ CAPITAL

                

Current liabilities:

                

Accounts payable:

                

Trade

   $ 436     $ 421  

Related parties

     46       38  

Current maturities of long-term debt

     31       32  

Accrued liabilities

     176       223  
    


 


Total current liabilities

     689       714  

Long-term debt

     2,223       2,196  

Other liabilities and deferred revenues

     391       221  

Commitments and contingencies

                

Partners’ capital:

                

Partners’ accounts

     1,763       1,958  

Accumulated other comprehensive loss

     (37 )     (37 )
    


 


Total partners’ capital

     1,726       1,921  
    


 


Total liabilities and partners’ capital

   $ 5,029     $ 5,052  
    


 


 

See Notes to the Consolidated Financial Statements.

 

2


EQUISTAR CHEMICALS, LP

 

CONSOLIDATED STATEMENTS OF CASH FLOWS

 

    

For the six

months ended
June 30,


 

Millions of dollars


   2003

    2002

 

Cash flows from operating activities:

                

Net loss

   $ (195 )   $ (1,207 )

Adjustments to reconcile net loss to cash provided by (used in) operating activities:

                

Cumulative effect of accounting change

     —         1,053  

Depreciation and amortization

     154       147  

Debt refinancing charge

     19       —    

Loss on sales of assets

     14       —    

Changes in assets and liabilities that provided (used) cash:

                

Accounts receivable

     66       (157 )

Inventories

     (66 )     3  

Accounts payable

     23       68  

Other assets and liabilities, net

     84       (46 )
    


 


Cash provided by (used in) operating activities

     99       (139 )
    


 


Cash flows from investing activities:

                

Proceeds from sales of assets

     54       —    

Expenditures for property, plant and equipment

     (34 )     (29 )

Contributions to affiliates

     —         (6 )
    


 


Cash provided by (used in) investing activities

     20       (35 )
    


 


Cash flows from financing activities:

                

Issuance of long-term debt

     440       —    

Repayment of long-term debt

     (440 )     (101 )

Net borrowing under lines of credit

     —         100  

Other

     (3 )     (2 )
    


 


Cash used in financing activities

     (3 )     (3 )
    


 


Increase (decrease) in cash and cash equivalents

     116       (177 )

Cash and cash equivalents at beginning of period

     27       202  
    


 


Cash and cash equivalents at end of period

   $ 143     $ 25  
    


 


 

See Notes to the Consolidated Financial Statements.

 

3


EQUISTAR CHEMICALS, LP

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

 

1.    Basis of Preparation

 

The accompanying consolidated financial statements are unaudited and have been prepared from the books and records of Equistar Chemicals, LP (“Equistar”) in accordance with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X for interim financial information. Accordingly, they do not include all of the information and notes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments, consisting only of normal, recurring adjustments, considered necessary for a fair presentation have been included. For further information, refer to the consolidated financial statements and notes thereto for the year ended December 31, 2002 included in the Equistar 2002 Annual Report on Form 10-K. Certain amounts from prior periods have been reclassified to conform to the current period presentation.

 

2.    Company Ownership

 

Equistar is a Delaware limited partnership, which commenced operations on December 1, 1997. Prior to August 2002, Equistar was owned 41% by Lyondell Chemical Company (“Lyondell”), 29.5% by Millennium Chemicals Inc. (“Millennium”) and 29.5% by Occidental Petroleum Corporation (“Occidental”). On August 22, 2002, Lyondell completed the purchase of Occidental’s interest in Equistar and, as a result, Lyondell’s ownership interest in Equistar increased to 70.5%.

 

3.    Accounting Changes

 

In May 2003, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards (“SFAS”) No. 150—Accounting for Certain Financial Instruments with Characteristics of Both Liabilities and Equity. The statement establishes standards for classifying and measuring certain financial instruments with characteristics of both liabilities and equity and requires that certain financial instruments be classified as liabilities, or assets in some circumstances. SFAS No. 150 is effective for financial instruments entered into or modified after May 31, 2003 and is otherwise effective for Equistar beginning in the third quarter 2003. Equistar does not expect SFAS No. 150 to have a material impact on its consolidated financial statements.

 

Equistar is implementing three accounting changes as discussed below.

 

Variable Interest Entities—In January 2003, the Financial Accounting Standards Board (“FASB”) issued Interpretation No. 46 (“FIN 46”), Consolidation of Variable Interest Entities. FIN 46 addresses certain situations in which a company should include in its financial statements the assets, liabilities and activities of another entity. FIN 46 applies immediately to entities created after January 31, 2003 and, for Equistar, applies to existing entities beginning in the third quarter 2003. The application of FIN 46 will result in the consolidation of an entity from which Equistar leases certain railcars. The consolidation of this entity as of June 30, 2003 would have resulted in a net increase in property, plant and equipment of $112 million, a decrease in prepaid expense of approximately $10 million and a $102 million increase in debt. The cumulative effect on income would not have been material.

 

Early Extinguishment of Debt—In April 2002, the FASB issued Statement of Financial Accounting Standards (“SFAS”) No. 145, Rescission of FASB Statements No. 4, 44, and 64, Amendment of FASB Statement No. 13, and Technical Corrections. The primary impact of the statement on Equistar is the classification of gains or losses that result from the early extinguishment of debt as an element of income before extraordinary items. The Consolidated Statements of Income and Comprehensive Income reflect these changes for all periods presented.

 

Goodwill and Other Intangible Assets—Effective January 1, 2002, Equistar adopted SFAS No. 142, Goodwill and Other Intangible Assets. Upon implementation of SFAS No. 142, Equistar reviewed goodwill for impairment and concluded that the entire balance of goodwill was impaired, resulting in a $1.1 billion charge that was reported as the cumulative effect of the accounting change as of January 1, 2002.

 

4


EQUISTAR CHEMICALS, LP

 

NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)—(Continued)

 

4.    Accounts Receivable

 

Under the terms of an October 2002 receivables sales agreement, Equistar agreed to sell, on an ongoing basis and without recourse, designated accounts receivable, up to a maximum of $100 million. The agreement is subject to Equistar maintaining its current debt rating by Standard & Poor’s rating service of the McGraw-Hill Companies and maintaining a rating no lower than one level below its current debt rating by Moody’s Investors Service. At June 30, 2003 and December 31, 2002, the balances of Equistar’s accounts receivable sold under this arrangement were $100 million and $81 million, respectively.

 

5.    Inventories

 

Inventories consisted of the following:

 

Millions of dollars


   June 30,
2003


   December 31,
2002


Finished goods

   $ 274    $ 233

Work-in-process

     14      12

Raw materials

     101      85

Materials and supplies

     89      94
    

  

Total inventories

   $ 478    $ 424
    

  

 

6.    Property, Plant and Equipment, Net

 

The components of property, plant and equipment, at cost, and the related accumulated depreciation were as follows:

 

Millions of dollars


   June 30,
2003


   December 31,
2002


Land

   $ 76    $ 80

Manufacturing facilities and equipment

     5,960      6,037

Construction in progress

     61      60
    

  

Total property, plant and equipment

     6,097      6,177

Less accumulated depreciation

     2,692      2,612
    

  

Property, plant and equipment, net

   $ 3,405    $ 3,565
    

  

 

Depreciation and amortization of asset costs is summarized as follows:

 

    

For the

three months

ended
June 30,


    

For the

six months

ended
June 30,